Emmanuelle Charpentier

2020 Nobel Prize in Chemistry Laureate. CRISPR-Cas9 Gene Editing Technique Co-Inventor

Speaker Fee Range: Please inquire for fees

Travels From: Berlin, Germany

Emmanuelle Charpentier is available for virtual keynotes and webinars. Please complete the form or contact one of our agents to inquire about the fees for virtual engagements. Please note: the fee range listed above is for in-person engagements.

Nobel Prize Speaker Emmanuelle Charpentier
REQUEST AVAILABILITY

Want to book Emmanuelle Charpentier for your event? Please provide the info below and we’ll get in touch within 24h:

    Emmanuelle Charpentier

    2020 Nobel Prize in Chemistry Laureate. CRISPR-Cas9 Gene Editing Technique Co-Inventor

    Speaker Fee Range: Please inquire for fees

    Travels From: Berlin, Germany

    Emmanuelle Charpentier is available for virtual keynotes and webinars. Please complete the form or contact one of our agents to inquire about the fees for virtual engagements. Please note: the fee range listed above is for in-person engagements.

    BOOK Emmanuelle Charpentier AS A SPEAKER

    Microbiologist, biochemist, and geneticist, winner of the Chemistry Nobel Prize in 2020. Keynote speaker Emmanuelle Charpentier has spent many years of her life researching human pathogens and has earned several awards thanks to her excellent work. Organizations book Emmanuelle Charpentier for her knowledge of the revolutionary CRISPR-Cas9 gene editing technology and her views into the future of science and genetics.

    Emmanuelle Charpentier Speaker Biography

    Keynote speaker Emmanuelle Charpentier is a French microbiologist, a biochemist, as well as a geneticist. Furthermore, she was the winner of the Chemistry Nobel Prize in 2020, together with Jennifer Doudna. They also co-won the 2020 Wolf Prize in Medicine. These two remarkable women have successfully developed new genome editing techniques.

    Following her studies in France, Emmanuelle began an intense scientific career in both Europe and the US. Emmanuelle has spent the majority of her professional career studying disease basic processes. Her research has put a strong emphasis on infections caused by Gram-positive bacterial pathogens, including staphylococci, Listeria, and streptococci.

    Emmanuelle has conducted plenty of lab work on the CRISPR-Cas9 acquired immune system in various bacteria. Her research laid the groundwork for the creation of a unique, extremely flexible, and specialized editing and engineering technique for genomes. The CRISPR-Cas technology is transforming life science studies. CRISPR-Cas has created a whole new potential for biotechnologies and biomedical gene therapies, with far-reaching implications for society and mankind. CRISPR-Cas biology and engineering continue to advance at an incredible rate, with fascinating new findings surfacing frequently.

    Emmanuelle Charpentier is a speaker who has earned several awards, honors, and doctorate degrees in Asia, North America, and Europe. She and her team’s contributions to the so-called CRISPR-Cas9 discovery led to them receiving numerous awards. Some of Charpentier’s awards include the Breakthrough Prize in Life Sciences, the Gruber Foundation International Prize in Genetic, as well as the Leibniz Prize

    Currently, she serves as an elected member of several scientific academies, both internationally and nationally. Emmanuelle is the co-owner and co-inventor of the CRISPR-Cas9 technology’s core intellectual property.

    She also co-founded ERS Genomics and CRISPR Therapeutics, together with Shaun Foy and Rodger Novak. Their goal was to develop the CRISPR-Cas technology for genome engineering for use in biotechnological and medicinal applications.

    Emmanuelle Charpentier Keynote Topics

    CRISPR/Cas9 allows scientists to easily alter DNA sequences and modify gene functions. Its many potential applications include correcting genetic defects, treating and preventing the spread of diseases. As a powerful tool for genome editing, its promise also raises ethical concerns.

    Emmanuelle Charpentier Speaking Videos

    Emmanuelle Charpentier - 21st Century Genetics: Genes at Work
    Emmanuelle Charpentier founder of the CRISPR-Cas9 gene editing technology